Results 171 to 180 of about 23,352 (209)
Some of the next articles are maybe not open access.
JAMA: The Journal of the American Medical Association, 1982
To the Editor.— Two cases of fatal aplastic anemia following the use of topical ocular chloramphenicol have been recently reported. 1,2 Regardless of dosage, systemic chloramphenicol can cause an idiosyncratic, usually fatal, hemopoietic event, with an incidence rate of one in 30,000 to 50,000 patients. This incidence is 13 times greater than the risk
openaire +2 more sources
To the Editor.— Two cases of fatal aplastic anemia following the use of topical ocular chloramphenicol have been recently reported. 1,2 Regardless of dosage, systemic chloramphenicol can cause an idiosyncratic, usually fatal, hemopoietic event, with an incidence rate of one in 30,000 to 50,000 patients. This incidence is 13 times greater than the risk
openaire +2 more sources
Annals of Internal Medicine, 1999
In aplastic anemia, hematopoiesis fails: Blood cell counts are extremely low, and the bone marrow appears empty. The pathophysiology of aplastic anemia is now believed to be immune-mediated, with active destruction of blood-forming cells by lymphocytes.
openaire +3 more sources
In aplastic anemia, hematopoiesis fails: Blood cell counts are extremely low, and the bone marrow appears empty. The pathophysiology of aplastic anemia is now believed to be immune-mediated, with active destruction of blood-forming cells by lymphocytes.
openaire +3 more sources
Aplastic Anemia and Splenectomy
Archives of Internal Medicine, 1967THE GRAVE prognosis associated with aplastic anemia is well established and has been repeatedly documented.1-3Various regimens have been explored in the management of this disease. These include either alone or in combinations, adrenocorticosteroids, androgens, and splenectomy.2,4 6Varying degrees of success have been reported and a number of ...
openaire +2 more sources
International Journal of Hematology, 2002
Aplastic anemia (AA) is more common in Asia than in Europe or the United States. This may be due in part to the high incidence of hepatitis-associated AA in Asia. The management of AA has evolved rapidly in Japan during the last decade. Advances in the treatment of AA have largely been the result of prospective collaborative studies of ...
openaire +2 more sources
Aplastic anemia (AA) is more common in Asia than in Europe or the United States. This may be due in part to the high incidence of hepatitis-associated AA in Asia. The management of AA has evolved rapidly in Japan during the last decade. Advances in the treatment of AA have largely been the result of prospective collaborative studies of ...
openaire +2 more sources
Journal of the American Pharmaceutical Association (1961), 1974
L E, Patterson, P G, Rigby
openaire +2 more sources
L E, Patterson, P G, Rigby
openaire +2 more sources
Cyclophosphamide for Aplastic Anemia
New England Journal of Medicine, 1978J, Pizzuto +4 more
openaire +2 more sources
Current evidence and the emerging role of eltrombopag in severe aplastic anemia
Therapeutic Advances in Hematology, 2021Beatrice Drexler
exaly